1 / 8

Monoclonal Antibodies Market Size, Share, Trends, Growth and Forecast Till 2028

According to our latest study on u201cMonoclonal Antibodies Market Size and Forecast to 2028 u2013 COVID-19 Impact and Global Analysis u2013 by Source, Production Method, Indication, Application, End-User,u201d the monoclonal antibodies market is projected to reach US$ 243.05 billion by 2028 from US$ 111.01 billion in 2021; it is expected to grow at a CAGR of 11.8% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market.

Download Presentation

Monoclonal Antibodies Market Size, Share, Trends, Growth and Forecast Till 2028

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Monoclonal Antibodies Market Global Analysis and Forecast to 2028 Published Date : Jan 2022 Email: sales@theinsightpartners.com

  2. Email: sales@theinsightpartners.com Report Studies  Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), and End-User (Hospitals, Others, and Research Institutes) 2

  3. Email: sales@theinsightpartners.com Monoclonal Antibodies Market Overview  The monoclonal antibodies market is projected to reach US$ 243.05 billion by 2028 from US$ 111.01 billion in 2021; it is expected to grow at a CAGR of 11.8% from 2021 to 2028.  The increasing prevalence of cancer and other chronic diseases, and a tremendous rise in COVID-19 cases across various regions are the key factors fueling the market growth. According to World Cancer Research Fund and American Institute for Cancer, in 2020, ~18.1 million cancer cases were recorded, including 9.3 million cases in men and 8.8 million cases in women. The use of monoclonal antibodies in the treatment of various types of cancer is still in phases 2 and phase 3 trials. 3

  4. Email: sales@theinsightpartners.com Key Segment Market Segment By Type:-  By Source (Human, Humanized, Chimeric, and Murine)  Application (Therapeutic Applications, Diagnostic Applications, and Research Applications)  End-User (Hospitals, Others, and Research Institutes) Download Sample Here 4

  5. Email: sales@theinsightpartners.com Monoclonal Antibodies Market Value $50,000 $40,000 $30,000 CAGR of 11.8% $20,000 (2021 - 2028) $10,000 $0 20XX 20XX 20XX 20XX 20XX Download Sample 5

  6. Email: sales@theinsightpartners.com Company Profiles  Novartis AG  Pfizer Inc.  GlaxoSmithKline plc  Amgen, Inc  Daiichi Sankyo Company, Limited  F. Hoffmann-La Roche AG  AstraZeneca  Elli Lily and Company  Bayer AG  Bristol-Myers Squibb Company Download Sample Here 6

  7. Email: sales@theinsightpartners.com By Geography  North America (the US, Canada, and Mexico)  Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe)  Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific)  Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa)  South & Central America (Brazil, Argentina, and the Rest of South & Central America). 7

  8. THANK YOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com

More Related